Form 4: Carlyle Group Sells Shares in QuidelOrtho Corp Under 10b5-1 Trading Plan

Carlyle Group executed sales of QuidelOrtho Corp shares on August 9, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Carlyle Group, a significant shareholder in QuidelOrtho Corp, has reported the sale of shares on August 9, 2024.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 12, 2024.
• A total of 6,344 shares were sold at a weighted average price of $40.8064, with individual prices ranging from $40.65 to $40.9885.
• An additional 67,790 shares were sold at a weighted average price of $41.6006, with individual prices ranging from $41.01 to $41.89.
• Following these transactions, Carlyle Group's indirect beneficial ownership stands at 8,260,183 shares.
• The reporting entities, including Carlyle Group Inc. and its affiliates, have disclaimed beneficial ownership of the securities held of record by Carlyle Partners VI Cayman Holdings, L.P.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing share sales by a major shareholder. It doesn't inherently convey positive or negative sentiment, but the market may react based on the size and context of the sale.

Risks

• The sale of shares by a major shareholder like Carlyle Group could potentially exert downward pressure on QuidelOrtho Corp's stock price in the short term.

Industry Context

Share sales by major holders are a normal part of market activity. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on current market information.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting transactions by company insiders and major shareholders, ensuring transparency in the market.
• Rule 10b5-1 trading plans are commonly used by corporate insiders to sell shares over time, mitigating concerns about trading on non-public information.
• Comparable companies such as Abbott Laboratories, Roche Holding AG, and Danaher Corporation also see similar filings from their major shareholders.

Stakeholder Impact

• Shareholders may react to the news of Carlyle Group selling shares, potentially influencing the stock price.
• The impact on employees, customers, suppliers, and creditors is likely to be minimal, as this is a financial transaction by a major shareholder.

Key Dates